Literature DB >> 15519841

[Management of acute visual loss in children].

D Doummar1, B Roussat, B Pelosse, H Ducou Le Pointe, M Iba-Zizen, A Roubergue, D Rodriguez, T Billette de Villemeur.   

Abstract

Acute or rapidly progressive visual loss in children needs urgent attention and treatment. It may be unilateral orbilateral. Etiology depends upon the involved areas: eye ball, optic nerve, retro-chiasmatic pathways. Psychogenic origin is quite common in school-age children, however, it has to be considered last. Unilateral visual loss may be overlooked. Acute total transitory visual loss may be due to epilepsy or to migraine. Rapidly progressive visual loss may be due to retinal disease, optic neuritis or cortical blindness. Management of visual loss depends on clinical features, associated symptoms, and aspect of the optic disc. It needs collaboration between ophthalmologist,pediatrician and neuropediatrician. Retinal hemorrhages first call to mind a traumatic origin. Swelling of the optic disc may be due to increased intracranial pressure or due to optic neuritis. When the optic disc is normal it is necessary to rule out organic diseases before establishing the diagnosis of a psychogenic vision disturbance. In emergency, brain neuroimaging is the best way to diagnose intracranial mass and visualize optic pathways.

Entities:  

Mesh:

Year:  2004        PMID: 15519841     DOI: 10.1016/j.arcped.2004.04.005

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  2 in total

1.  Child Neurology: Bartonella henselae Neuroretinitis in 2 Patients.

Authors:  Blazo Nikolic; Nikola Ivancevic; Ana Pepic; Marijana Kovacevic; Jelena Mladenovic; Branislav Rovcanin; Janko Samardzic; Jasna Jancic
Journal:  Neurology       Date:  2022-03-29       Impact factor: 11.800

2.  Acute loss of vision in a young woman: a case report on psychogenic blindness.

Authors:  S Mulugeta; K Tesfay; R Frank; C Gruber-Frank
Journal:  Ethiop J Health Sci       Date:  2015-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.